DOLOREX DIN 02462923
Status: Marketed
Holder: INTERVET CANADA CORP
Health Canada record
| Active ingredient(s) | BUTORPHANOL (BUTORPHANOL TARTRATE) 10 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | CONTROLLED DRUGS (CDSA IV) |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 30-Jan-2018 |
|---|
| Current status date | 30-Jan-2018 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Intervet Canada Corp. — licence 100147, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BUTORPHANOL (BUTORPHANOL TARTRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02570343 | BUTOMIDOR | VETVIVA RICHTER GMBH | Solution | BUTORPHANOL (BUTORPHANOL TARTRATE) 10 MG | Approved |
| 00845000 | TORBUGESIC | ZOETIS CANADA INC | Solution | BUTORPHANOL (BUTORPHANOL TARTRATE) 10 MG | Marketed |
| 02496402 | TORPHADINE | DECHRA REGULATORY BV | Solution | BUTORPHANOL (BUTORPHANOL TARTRATE) 10 MG | Marketed |
| 00844977 | TORBUTROL | ZOETIS CANADA INC | Tablet | BUTORPHANOL (BUTORPHANOL TARTRATE) 1 MG | Dormant |
| 00844985 | TORBUTROL | ZOETIS CANADA INC | Tablet | BUTORPHANOL (BUTORPHANOL TARTRATE) 5 MG | Dormant |
| 00844993 | TORBUTROL (BUTORPHANOL TARTRATE 10MG TABLET) | WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA | Tablet | BUTORPHANOL (BUTORPHANOL TARTRATE) 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 19143 | 2017-04-10 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for DOLOREX
How to read a Canadian DIN record